Prostate Cancer Research (PCR) and the NHS have joined forces to provide unique access to healthcare data for research that will transform patient care and treatment of the disease.
Prostate Progress, a revolutionary project publicly launched by PCR on July 23rd, has been selected as the first ‘driver project’ to take part in NHS England’s Data for Research and Development Programme. It will support innovative uses of health data to solve real world problems.
Prostate Progress provides safe and secure access to the medical records of prostate cancer patients who agree to take part, alongside data they directly input – such as how they are feeling and the real-life effects of their cancer and its treatment. Researchers hope to gain unique insights into the disease by combining the two sets of data.
Stephen Fry, who has previously had prostate cancer surgery, is keen to encourage others living with a diagnosis to get involved with the project.
“Prostate Progress represents a beacon of hope in the fight against prostate cancer, a disease that impacts countless lives globally.
“By harnessing the power of our own health information, we empower researchers to unlock vital insights, leading to ground-breaking advancements. We can bring the world closer to a future where this disease is no longer a threat, where early detection and effective, humane treatment saves lives.
“I am excited to be part of Prostate Progress and urge others to join me.”
Stephen Fry
Anyone diagnosed with prostate cancer, either recently or in the past, is encouraged to take part in Prostate Progress. You can find out more information at www.pcr.org.uk/Prostate-Progress.
Over 1,000 people have already signed up, will you join them and help save lives?
Vin Diwakar, National Director of Transformation at NHS England, said:
“This unique collaboration with Prostate Cancer Research will provide new insights into prostate cancer and improve care for patients.
“The NHS Research Secure Data Environment Network allows us to link data and enable research at a scale not previously possible, while maintaining the highest levels of security.
“Researchers will benefit from the rich picture provided from both NHS clinical data as well as information from patients who volunteer to take part and share their experiences.
“I’d encourage anyone who has had prostate cancer to sign up for Prostate Progress and help save lives.”